Cdk6 shRNA Plasmid (h) from Santa Cruz Biotechnology, Inc.

10410 Finnell Street

Dallas, Texas 75220

United States

Phone: 1-800-457-3801
831-457-3801

(1) Co-targeting RANK pathway treats and prevents acquired resistance to CDK4/6 inhibitors in luminal breast cancerCell reports. MedicineAugust 15, 2023Gomes I, Gallego-Paez LM, Jiménez M, Santamaria PG, Mansinho A, Sousa R, Abreu C, Suárez EG, Costa L, Casimiro S.

(3) miR-6883 Family miRNAs Target CDK4/6 to Induce G₁ Phase Cell-Cycle Arrest in Colon Cancer CellsCancer researchDecember 15, 2017Lulla AR, Slifker MJ, Zhou Y, Lev A, Einarson MB, Dicker DT, El-Deiry WS.

(5) Multiple CDK/CYCLIND genes are amplified in medulloblastoma and supratentorial primitive neuroectodermal brain tumorCancer geneticsMay 1, 2012Li M, Lockwood W, Zielenska M, Northcott P, Ra YS, Bouffet E, Yoshimoto M, Rutka JT, Yan H, Taylor MD, et al.

(6) MiR-125b is critical for the suppression of human U251 glioma stem cell proliferationBrain researchFebruary 2, 2010Shi L, Zhang J, Pan T, Zhou J, Gong W, Liu N, Fu Z, You Y.

(7) A role for NANOG in G1 to S transition in human embryonic stem cells through direct binding of CDK6 and CDC25AThe Journal of cell biologyJanuary 12, 2009Zhang X, Neganova I, Przyborski S, Yang C, Cooke M, Atkinson SP, Anyfantis G, Fenyk S, Keith WN, Hoare SF, et al.

Cdk6 shRNA Plasmid (h)